RxDoctor Payments Data

Harsha Vittal, MD

Gastroenterology · San Jose, CANPI 1245308931

Payments from drug & device makers

$1,516in general payments, 2019–2025

Across 19 payments — averaging $79.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ERBE USA Inc$726
  • Boston Scientific$257
  • 3-d Matrix, Inc.$235
  • Globus Medical$150
  • Endogastric Solutions, Inc$124
  • Takeda Pharmaceuticals U.S.A., Inc.$16
  • plus $8 from 1 others

What the payments were for

  • Food & beverage$1,516100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
ERBE USA Inc7$726
Boston Scientific5$257
3-d Matrix, Inc.1$235
Globus Medical1$150
Endogastric Solutions, Inc2$124
Takeda Pharmaceuticals U.S.A., Inc.2$16
Apollo Endosurgery US Inc1$8

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,516 in reported general payments places this provider in the 40th percentile of 1,885 gastroenterology providers in California.

See all gastroenterology providers in California

Medicare billing

Part B allowed, 2024
$182,220
Medicare patients
452
Services billed
939

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates68$4,574
Budesonide EcBudesonide12$2,224
Pantoprazole Sodium96$1,505
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg33$615
Nortriptyline Hcl13$165
Omeprazole17$153

Paid to pharmacies, not to this prescriber.

Other gastroenterology in San Jose

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →